Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia

Abstract Besides chemotherapy and hematopoietic stem cell transplantation (HSCT), autologous T cells can also serve as a new treatment approach for AML patients. However, the features of tumor-reactive T cells and their distinctive markers still lack full description. To evaluate the characteristics...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yihan Mei, Yu Liu, Wenbing Liu, Manling Chen, Xiaoyu Liu, Shangshang Wang, Junli Mou, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Runxia Gu, Shaowei Qiu, Jianxiang Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-09-01
Col·lecció:	Experimental Hematology & Oncology
Matèries:	AML Tumor-reactive T cell ADGRG1
Accés en línia:	https://doi.org/10.1186/s40164-024-00560-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!